144 related articles for article (PubMed ID: 36403750)
21. The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions.
Blum A; Soyer HP; Garbe C; Kerl H; Rassner G; Hofmann-Wellenhof R
Br J Dermatol; 2003 Dec; 149(6):1159-64. PubMed ID: 14674892
[TBL] [Abstract][Full Text] [Related]
22. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
23. "Lentiginous melanoma": full-fledged melanoma or melanoma precursor?
Mooi WJ
Adv Anat Pathol; 2014 May; 21(3):181-7. PubMed ID: 24713988
[TBL] [Abstract][Full Text] [Related]
24. An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis.
Abraham RM; Ming ME; Elder DE; Xu X
J Cutan Pathol; 2012 Jan; 39(1):21-4. PubMed ID: 22211332
[TBL] [Abstract][Full Text] [Related]
25. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
26. Melanocytic tumour with unknown malignant potential--a Danish study of 67 patients.
Kaltoft B; Hainau B; Lock-Andersen J
Melanoma Res; 2015 Feb; 25(1):64-7. PubMed ID: 25396682
[TBL] [Abstract][Full Text] [Related]
27. Borderline and atypical melanocytic lesions.
Brodell RT; Santa Cruz DJ
Semin Diagn Pathol; 1985 Feb; 2(1):63-86. PubMed ID: 3916688
[TBL] [Abstract][Full Text] [Related]
28. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
29. Polypoid Compound Melanocytic Proliferations: A Clinicopathological Study.
Mesbah Ardakani N; Harvey NT; Wood BA
Am J Dermatopathol; 2019 Aug; 41(8):578-584. PubMed ID: 31335410
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
31. Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions.
Rudolph P; Schubert C; Schubert B; Parwaresch R
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):169-78. PubMed ID: 9270500
[TBL] [Abstract][Full Text] [Related]
32. Preferentially expressed Antigen in MElanoma immunohistochemistry as an adjunct for evaluating ambiguous melanocytic proliferation.
Fattori A; de la Fouchardière A; Cribier B; Mitcov M
Hum Pathol; 2022 Mar; 121():19-28. PubMed ID: 34990622
[TBL] [Abstract][Full Text] [Related]
33. Certain and uncertain malignant potential in melanocytic skin neoplasms.
Urso C
J Cutan Pathol; 2019 Sep; 46(9):711-712. PubMed ID: 31206767
[No Abstract] [Full Text] [Related]
34. Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma.
Robson A; Morley-Quante M; Hempel H; McKee PH; Calonje E
Histopathology; 2003 Dec; 43(6):529-37. PubMed ID: 14636253
[TBL] [Abstract][Full Text] [Related]
35. Histopathological diagnosis of small melanocytic lesions suspicious for malignant melanoma.
Quintella DC; Campos-do-Carmo G; Quintella LP; Cuzzi T
An Bras Dermatol; 2017; 92(3):375-378. PubMed ID: 29186251
[TBL] [Abstract][Full Text] [Related]
36. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
37. Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic.
Hawryluk EB; Sober AJ; Piris A; Nazarian RM; Hoang MP; Tsao H; Mihm MC; Duncan LM
J Am Acad Dermatol; 2012 Oct; 67(4):727-35. PubMed ID: 22521204
[TBL] [Abstract][Full Text] [Related]
38. BAM! Utilizing the frequency of Benign, Atypical and Malignant diagnoses for quality improvement in the histopathologic diagnosis of melanocytic neoplasms.
Bush JW; Hunt EL; Fraga GR
J Cutan Pathol; 2015 Oct; 42(10):712-6. PubMed ID: 26260628
[TBL] [Abstract][Full Text] [Related]
39. Histopathological characteristics of malignant melanoma affecting mucous membranes: a unifying concept of histogenesis.
Saida T; Kawachi S; Takata M; Kurita H; Kurashina K; Kageshita T; Tonogi M; Okazaki Y; Yamane GY; Takubo K; Ueyama Y
Pathology; 2004 Oct; 36(5):404-13. PubMed ID: 15370109
[TBL] [Abstract][Full Text] [Related]
40. Expanding spectrum of "spitzoid" lesions: a small series of 4 cases with MAP2K1 mutations.
Kerckhoffs KGP; Aallali T; Ambarus CA; Sigurdsson V; Jansen AML; Blokx WAM
Virchows Arch; 2021 Jul; 479(1):195-202. PubMed ID: 33040161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
